Jiangwei Zhang
Scientific Associate Director @Bristol Myers Squibb
Signup · Get unlimited contacts
WORK HISTORY
Scientific Associate Director @Bristol Myers Squibb
San Diego, CA, US
Responsible for translational medicine and clinical biomarker activities to support ZEPOSIA ph drug development programs in inflammatory bowel disease (IBD, UC & CD) and COBENFY ph drug development programs in neuropsychiatric disease (schizophrenia, bipolar disorder, ASD etc.)• Serving as clinical biomarker lead on study teams, setting up biomarker plans for individual trials and ensuring appropriate collection of, timely analysis and reporting of final biomarker data• Responsible for addressing key translational medicine questions related to the assigned assets and diseases via collaboration with internal clinical/medical team and/or academic thought leaders• Collaborating with project teams, clinical scientists, clinical physicians, statisticians, computational biologists and contract research organizations (CRO) to deliver science that supports the late-stage development of medicines
EDUCATION
Nanchang University
Bachelor's degree, Food Chemistry
China Agricultural University
Doctor of Philosophy (Ph.D.), Food Biotechnology, Proteomics
Nanchang University
Master's degree, Food Microbiology
SKILLS
ABOUT JIANGWEI ZHANG
Summary:• Over 10 years research experience in cancer biology, immunology, metabolic and neurological diseases.• Extensive experience in clinical biomarker and translational medicine research for ph stage drug development.• Extensive experience in the development of antisense oligonucleotides (ASO) based drug discovery platform from preclinical proof of concept (POC) study to human clinical candidate selection. • Proven track record with high impact publications including first/co-author papers in Nature Cell Biology, Science Translational Medicine, and Cell Reports.• Manage the external collaboration with academic researches and industry alliances.• Supervise and mentor direct reports.Specialities:• Drug Discovery; • Clinical Biomarker Discovery & Development; Translational Medicine; • Late-stage Clinical Development; • Multi-Omics Technologies; • Cancer Biology; • Immunology; • Metabolic Disease; • In vitro & In vivo Pharmacology; • RNA Therapeutics; • Small & Large Molecule Therapeutics • Pharm Partnerships; • Academic Collaborations; • CRO Management
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.